Embedding Biomimetic Magnetic Nanoparticles Coupled with Peptide AS-48 into PLGA to Treat Intracellular Pathogens
-
Published:2022-12-08
Issue:12
Volume:14
Page:2744
-
ISSN:1999-4923
-
Container-title:Pharmaceutics
-
language:en
-
Short-container-title:Pharmaceutics
Author:
Gaglio Salvatore Calogero, Jabalera YleniaORCID, Montalbán-López ManuelORCID, Millán-Placer Ana Cristina, Lázaro-Callejón MarinaORCID, Maqueda Mercedes, Carrasco-Jimenez María PazORCID, Laso Alejandro, Aínsa José A.ORCID, Iglesias Guillermo R.ORCID, Perduca MassimilianoORCID, López Concepción JiménezORCID
Abstract
Among the strategies employed to overcome the development of multidrug-resistant bacteria, directed chemotherapy combined with local therapies (e.g., magnetic hyperthermia) has gained great interest. A nano-assembly coupling the antimicrobial peptide AS-48 to biomimetic magnetic nanoparticles (AS-48-BMNPs) was demonstrated to have potent bactericidal effects on both Gram-positive and Gram-negative bacteria when the antimicrobial activity of the peptide was combined with magnetic hyperthermia. Nevertheless, intracellular pathogens remain challenging due to the difficulty of the drug reaching the bacterium. Thus, improving the cellular uptake of the nanocarrier is crucial for the success of the treatment. In the present study, we demonstrate the embedding cellular uptake of the original nano-assembly into THP-1, reducing the toxicity of AS-48 toward healthy THP-1 cells. We optimized the design of PLGA[AS-48-BMNPs] in terms of size, colloidal stability, and hyperthermia activity (either magnetic or photothermal). The stability of the nano-formulation at physiological pH values was evaluated by studying the AS-48 release at this pH value. The influence of pH and hyperthermia on the AS-48 release from the nano-formulation was also studied. These results show a slower AS-48 release from PLGA[AS-48-BMNPs] compared to previous nano-formulations, which could make this new nano-formulation suitable for longer extended treatments of intracellular pathogens. PLGA[AS-48-BMNPs] are internalized in THP-1 cells where AS-48 is liberated slowly, which may be useful to treat diseases and prevent infection caused by intracellular pathogens. The treatment will be more efficient combined with hyperthermia or photothermia.
Funder
FEDER Operational Program Proyectos de I + D + I, del Plan Andaluz de Investigación, Desarrollo e Innovación Instituto de Salud Carlos III MINECO Federation of European Microbiological Societies
Subject
Pharmaceutical Science
Reference53 articles.
1. Antimicrobial Resistance: Risk Associated with Antibiotic Overuse and Initiatives to Reduce the Problem;Llor;Ther. Adv. Drug Saf.,2014 2. Nanobead-Based Interventions for the Treatment and Prevention of Tuberculosis;Griffiths;Nat. Rev. Microbiol.,2010 3. Wu, B., Fu, J., Zhou, Y., Wang, J., Feng, X., Zhao, Y., Lu, C., Quan, G., and Pan, X. (2019). Metal–Organic Framework-Based Chemo-Photothermal Combinational System for Precise, Rapid, and Efficient Antibacterial Therapeutics. Pharmaceutics, 11. 4. Wang, H., Zhao, B., Dong, W., Zhong, Y., Zhang, X., Gong, Y., Zhan, R., Xing, M., Zhang, J., and Luo, G. (2020). A Dual-Targeted Platform Based on Graphene for Synergistic Chemo-Photothermal Therapy against Multidrug-Resistant Gram-Negative Bacteria and Their Biofilms. Chem. Eng. J., 393. 5. Antibacterial Directed Chemotherapy Using AS-48 Peptide Immobilized on Biomimetic Magnetic Nanoparticles Combined with Magnetic Hyperthermia;Jabalera;Int. J. Biol. Macromol.,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|